Download this comprehensive analysis of over 53 million distinct cardiovascular patients from the Veradigm Network EHR database of de-identified real world data. You’ll gain access to a thorough ...
WASHINGTON (September 24, 2025) — Cardiovascular diseases (CVD) remain the leading cause of disease burden , causing one in three deaths worldwide as a result of population growth, population aging ...
Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on ...
Cardiovascular diseases (CVD) remain the leading cause of disease burden, causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results